Symptomatic and asymptomatic benign prostatic hyperplasia: Molecular differentiation by using microarrays

被引:95
作者
Prakash, K
Pirozzi, G
Elashoff, M
Munger, W
Waga, I
Dhir, R
Kakehi, Y
Getzenberg, RH
机构
[1] Gene Log Inc, Gaithersburg, MD 20878 USA
[2] Univ Pittsburgh, Sch Med, Dept Urol Pathol & Pharmacol, Pittsburgh, PA 15213 USA
[3] Univ Pittsburgh, Sch Med, Univ Pittsburgh Canc Inst, Pittsburgh, PA 15213 USA
[4] Japan Tobacco Inc, Pharmaceut Frontier Res Labs, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[5] Kagawa Med Univ, Dept Urol, Kagawa 7610793, Japan
关键词
D O I
10.1073/pnas.112191399
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Benign prostatic hyperplasia (BPH) is a disease of unknown etiology that significantly affects the quality of life in aging men. Histologic BPH may present itself either as symptomatic or asymptomatic in nature. To elucidate the molecular differences underlying BPH, gene expression profiles from the prostate transition zone tissue have been analyzed by using microarrays. A set of 511 differentially expressed genes distinguished symptomatic and asymptomatic BPH. This genetic signature separates BPH from normal tissue but does not seem to change with age. These data could provide novel approaches for alleviating symptoms and hyperplasia in BPH.
引用
收藏
页码:7598 / 7603
页数:6
相关论文
共 32 条
[1]   Characterisation of inflammatory cells in benign prostatic hyperplasia [J].
Anim, JT ;
Udo, C ;
John, B .
ACTA HISTOCHEMICA, 1998, 100 (04) :439-449
[2]   Dihydrotestosterone and the concept of 5α-reductase inhibition in human benign prostatic hyperplasia [J].
Bartsch, G ;
Rittmaster, RS ;
Klocker, H .
EUROPEAN UROLOGY, 2000, 37 (04) :367-380
[3]  
Berthon P, 1997, INT J CANCER, V73, P910
[4]  
Brinkmann U, 1999, CANCER RES, V59, P1445
[5]   PAGE-1, an X chromosome-linked GAGE-like gene that is expressed in normal and neoplastic prostate, testis, and uterus [J].
Brinkmann, U ;
Vasmatzis, G ;
Lee, BK ;
Yerushalmi, N ;
Essand, M ;
Pastan, I .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (18) :10757-10762
[6]   Identification of potential diagnostic markers of prostate cancer and prostatic intraepithelial neoplasia using cDNA microarray [J].
Bull, JH ;
Ellison, G ;
Patel, A ;
Muir, G ;
Walker, M ;
Underwood, M ;
Khan, F ;
Paskins, L .
BRITISH JOURNAL OF CANCER, 2001, 84 (11) :1512-1519
[7]  
Cabelin M A, 2000, Curr Opin Urol, V10, P301, DOI 10.1097/00042307-200007000-00003
[8]  
Caprino L, 2000, Minerva Urol Nefrol, V52, P87
[9]   New concepts in tissue specificity for prostate cancer and benign prostatic hyperplasia [J].
De Marzo, AM ;
Coffey, DS ;
Nelson, WG .
UROLOGY, 1999, 53 (03) :29-40
[10]  
DEBOUCK C, 1999, NATURE, V21, P658